Relationship of antioxidant and oxidative stress markers in different organs following copper toxicity in a rat model

Toxicology and Applied Pharmacology

Volumn 293, Issue , 2016, Pages 37-43

  Kumar, Vijay ^a   Kalita, Jayantee ^a   Bora, Himangsu K ^b   Misra, Usha K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Copper toxicity; Glutathione; Lipid peroxidation; Oxidative stress; Rat; Total antioxidant capacity; Wilson disease

Indexed keywords

COPPER; CREATININE; GLUTATHIONE; MALONALDEHYDE;

ANIMAL; ANIMAL BEHAVIOR; BLOOD; BRAIN; DRUG EFFECTS; EXPLORATORY BEHAVIOR; HAND STRENGTH; KIDNEY; LIVER; MALE; METABOLISM; OXIDATIVE STRESS; ROTAROD TEST; UREA NITROGEN BLOOD LEVEL; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD UREA NITROGEN; BRAIN; COPPER; CREATININE; EXPLORATORY BEHAVIOR; GLUTATHIONE; HAND STRENGTH; KIDNEY; LIVER; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS, WISTAR; ROTAROD PERFORMANCE TEST;

EID: 84954206024     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2016.01.007     Document Type: Article

References (47)

1. Alexandrova A., Petrov L., Georgieva A., et al. Effect of copper intoxication on rat liver proteasome activity: relationship with oxidative stress. J. Biochem. Mol. Toxicol. 2008, 22:354-362.
2. Arnal N., Dominici L., de Tacconi M.J., Marra C.A. Copper-induced alterations in rat brain depends on route of overload and basal copper levels. Nutrition 2014, 30:96-106.
3. Boveris A., Musacco-Sebio R., Ferrarotti N., et al. The acute toxicity of iron and copper: biomolecule oxidation and oxidative damage in rat liver. J. Inorg. Biochem. 2012, 116:63-69.
4. Brewer G.J. Risks of copper and iron toxicity during aging in humans. Chem. Res. Toxicol. 2010, 23:319-326.
5. Bruha R., Vitek L., Marecek Z., et al. Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. J. Inherit. Metab. Dis. 2012, 35:541-548.
6. Bulcke F., Santofimia-Castano P., Gonzalez-Mateos A., Dringen R. Modulation of copper accumulation and copper-induced toxicity by antioxidants and copper chelators in cultured primary brain astrocytes. J. Trace Elem. Med. Biol. 2015, 32:168-176.
7. Choi B.S., Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res. 2009, 1248:14-21.
8. Cisternas F.A., Tapia G., Arredondo M., et al. Early histological and functional effects of chronic copper exposure in rat liver. Biometals 2005, 18:541-551.
9. Council NR Nutrient Requirements of Laboratory Animals, Fourth Revised Edition, 1995 1995, The National Academies Press, Washington, DC.
10. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci. 1996, 16:2553-2562.
11. Dringen R., Scheiber I.F., Mercer J.F. Copper metabolism of astrocytes. Front. Aging Neurosci. 2013, 5:9.
12. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
13. Freedman J.H., Ciriolo M.R., Peisach J. The role of glutathione in copper metabolism and toxicity. J. Biol. Chem. 1989, 264:5598-5605.
14. Gaetke L.M., Chow C.K. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003, 189:147-163.
15. Gaggelli E., Kozlowski H., Valensin D., Valensin G. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem. Rev. 2006, 106:1995-2044.
16. Hasan M., Haider S.S. Acetyl-homocysteine thiolactone protects against some neurotoxic effects of thallium. Neurotoxicology 1989, 10:257-261.
17. Hayashi M., Kuge T., Endoh D., et al. Hepatic copper accumulation induces DNA strand breaks in the liver cells of Long-Evans Cinnamon strain rats. Biochem. Biophys. Res. Commun. 2000, 276:174-178.
18. Hayashi M., Fuse S., Endoh D., et al. Accumulation of copper induces DNA strand breaks in brain cells of Long-Evans Cinnamon (LEC) rats, an animal model for human Wilson Disease. Exp. Anim. 2006, 55:419-426.
19. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
20. Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345:91-104.
21. Joseph B., Kapoor S., Schilsky M.L., Gupta S. Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model. Hepatology 2009, 49:1616-1624.
22. Kalita J., Kumar V., Misra U.K., Ranjan A., Khan H., Konwar R. A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings. J. Neuroimmunol. 2014, 274:141-148.
23. Kalita J., Kumar V., Ranjan A., Misra U.K. Role of oxidative stress in the worsening of neurologic Wilson disease following chelating therapy. Neruomol. Med. 2015.
24. Kalita J., Kumar V., Misra U.K. A study on apoptosis and anti-apoptotic status in Wilson disease. Mol. Neurobiol. 2015, 1-9.
25. Koracevic D., Koracevic G., Djordjevic V., Andrejevic S., Cosic V. Method for the measurement of antioxidant activity in human fluids. J. Clin. Pathol. 2001, 54:356-361.
26. Kumar V., Kalita J., Misra U.K., Bora H.K. A study of dose response and organ susceptibility of copper toxicity in a rat model. J. Trace Elem. Med. Biol. 2015, 29:269-274.
27. Leiva J., Palestini M., Infante C., Goldschmidt A., Motles E. Copper suppresses hippocampus LTP in the rat, but does not alter learning or memory in the Morris water maze. Brain Res. 2009, 1256:69-75.
28. Linder M.C., Hazegh-Azam M. Copper biochemistry and molecular biology. Am. J. Clin. Nutr. 1996, 63:797S-811S.
29. Linder M.C., Wooten L., Cerveza P., Cotton S., Shulze R., Lomeli N. Copper transport. Am. J. Clin. Nutr. 1998, 67:965S-971S.
30. Mattie M.D., Freedman J.H. Copper-inducible transcription: regulation by metal- and oxidative stress-responsive pathways. Am. J. Physiol. Cell. Physiol. 2004, 286:C293-C301.
31. Musacco-Sebio R., Ferrarotti N., Saporito-Magrina C., et al. Oxidative damage to rat brain in iron and copper overloads. Metallomics 2014, 6:1410-1416.
32. Nagasaka H., Takayanagi M., Tsukahara H. Children's toxicology from bench to bed-liver injury (3): oxidative stress and anti-oxidant systems in liver of patients with Wilson disease. J. Toxicol. Sci. 2009, 34(Suppl. 2):SP229-SP236.
33. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
34. Ozcelik D., Uzun H. Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biol. Trace Elem. Res. 2009, 127:45-52.
35. Ozcelik D., Ozaras R., Gurel Z., Uzun H., Aydin S. Copper-mediated oxidative stress in rat liver. Biol. Trace Elem. Res. 2003, 96:209-215.
36. Pal A., Badyal R.K., Vasishta R.K., Attri S.V., Thapa B.R., Prasad R. Biochemical, histological, and memory impairment effects of chronic copper toxicity: a model for non-Wilsonian brain copper toxicosis in Wistar rat. Biol. Trace Elem. Res. 2013, 153:257-268.
37. Pal A., Vasishta R., Prasad R. Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in Wistar rat model for non-Wilsonian brain copper toxicosis. Biol. Trace Elem. Res. 2013, 154:403-411.
38. Palm R., Wahlstrom G., Hallmans G. Age related changes in weight and the concentrations of zinc and copper in the brain of the adult rat. Lab. Anim. 1990, 24:240-245.
39. Przybylkowski A., Gromadzka G., Wawer A., et al. Neurochemical and behavioral characteristics of toxic milk mice: an animal model of Wilson's disease. Neurochem. Res. 2013, 38:2037-2045.
40. Samuele A., Mangiagalli A., Armentero M.T., et al. Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim. Biophys. Acta 1741, 2005:325-330.
41. Scheiber I.F., Dringen R. Astrocyte functions in the copper homeostasis of the brain. Neurochem. Int. 2013, 62:556-565.
42. Schosinsky K.H., Lehmann H.P., Beeler M.F. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin. Chem. 1974, 20:1556-1563.
43. Shim H., Harris Z.L. Genetic defects in copper metabolism. J. Nutr. 2003, 133:1527S-1531S.
44. Summer K.H., Eisenburg J. Low content of hepatic reduced glutathione in patients with Wilson's disease. Biochem. Med. 1985, 34:107-111.
45. Turnlund J.R. Human whole-body copper metabolism. Am. J. Clin. Nutr. 1998, 67:960S-964S.
46. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12:1161-1208.
47. Valko M., Jomova K., Rhodes C.J., Kuca K., Musilek K. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch. Toxicol. 2015.